ELAN
What one share of Elanco Animal Health Incorporated holds
Pharmaceutical Preparations
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets.
Elanco Animal Health Incorporated’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $10.05 |
|---|---|
| Profit | −$0.40 |
| Capex (buildings and equipment) | $0.48 |
| Free cash flow | $0.76 |
| Cash and investments | $1.06 |
| Debt | $7.33 |
| Book value | $13.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $9.93 | −$0.16 | $0.38 | $0.16 | — | $23.93 |
| 2017 | $9.85 | −$1.06 | $0.34 | $0.26 | — | $21.28 |
| 2018 | $9.78 | $0.28 | $0.43 | $1.12 | — | $14.21 |
| 2019 | $8.29 | $0.18 | $0.38 | $0.23 | — | $14.86 |
| 2020 | $7.42 | −$1.30 | $0.31 | −$0.40 | — | $17.92 |
| 2021 | $9.78 | −$0.99 | $0.33 | $0.67 | — | $15.87 |
| 2022 | $9.03 | −$0.16 | $0.35 | $0.58 | — | $15.37 |
| 2023 | $8.97 | −$2.50 | $0.28 | $0.27 | — | $12.63 |
| 2024 | $8.93 | $0.68 | $0.30 | $0.79 | — | $12.33 |
| 2025 | $9.50 | −$0.47 | $0.56 | $0.57 | — | $13.17 |